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OBJECTIVES The goal of this study was to evaluate the role of diastolic blood pressure (DBP) in
cardiovascular mortality for different systolic blood pressure (SBP) levels in middle-aged men
and women.
BACKGROUND In middle-aged subjects it is unclear whether DBP, in addition to SBP, should be considered
for risk evaluation.
METHODS Subjects (77,023 men; 48,480 women) aged 40 to 70 years old, had no major cardiovascular
disease, no antihypertensive treatment and were examined at the Centre d’Investigations
Pre´ventives et Cliniques between 1972 and 1988. Mortality was assessed for an 8- to 12-year
period.
RESULTS In both genders, cardiovascular mortality increased with the SBP level. In men and women
with normal SBP levels, DBP did not influence cardiovascular mortality after adjustment for
age and SBP. In men with systolic hypertension, a U-shaped curve relationship between
cardiovascular mortality and DBP was observed, with the lowest mortality rates in the group
with DBP 90 to 99 mm Hg. Compared with this group, age- and SBP-adjusted
cardiovascular mortality was higher by 73% (p , 0.02) in the group with DBP ,90 mm Hg
and by 65% (p , 0.001) in the group with DBP $110 mm Hg. In women with systolic
hypertension, however, DBP was positively correlated with cardiovascular mortality.
CONCLUSIONS In middle-aged subjects, classification of cardiovascular risk according to DBP levels should
take into account gender, especially when SBP levels are elevated. Men with systolic
hypertension are at higher risk when their DBP is “normal” than when they present a mild
to moderate increase in DBP. In women of the same age, however, systolic-diastolic
hypertension represents a higher risk than isolated systolic hypertension. (J Am Coll Cardiol
2001;37:163–8) © 2001 by the American College of Cardiology
In various epidemiological studies, a strong positive rela-
tionship between cardiovascular disease and blood pressure
(BP) has been reported (1,2). Both systolic blood pressure
(SBP) and diastolic blood pressure (DBP) have been shown
to be associated with cardiovascular risk. In the 1970s and
early 1980s, most international medical authorities sug-
gested that DBP was the main determinant of cardiovascu-
lar risk. More recently, the importance of SBP has also been
pointed out, especially in older subjects (3,4). The Sixth
Report of the Joint National Committee on Prevention,
Detection, Evaluation and Treatment of High Blood Pres-
sure (5) and the recent report of the World Health Orga-
nization/International Society of Hypertension (6) classified
BP into stages based on either SBP or DBP levels. Both
classifications define the lowest SBP and DBP levels as
being the optimal levels and the highest levels of both SBP
and DBP as being the levels with the highest cardiovascular
morbidity and mortality. During the last years however, a
large number of studies have suggested that in several
populations, pulse pressure (PP 5 SBP-DBP) is a major
indicator, if not the best, of cardiovascular risk (7–9). These
observations suggest that more attention should be given to
SBP and PP since both of them may play a greater role in
determining cardiovascular risk than DBP (10–12). Isolated
systolic hypertension is identified as a particular form of
hypertension that requires treatment, but it is generally
thought that isolated systolic hypertension is a risk factor
only in older subjects. For middle-aged subjects it is unclear
whether or not for a given level of SBP, cardiovascular risk
is proportional to the level of DBP. The majority of
clinicians think that having both an elevated SBP and DBP
is a more important risk factor than having an isolated
increase in SBP. It is also unclear whether or not the role of
DBP is influenced by gender.
The aim of this study was to evaluate the role of DBP in
cardiovascular mortality for different SBP levels in middle-
aged men and women. This study was conducted in a large
French population of 77,023 men and 48,480 women
examined at the Center d’Investigations Pre´ventives et
Cliniques (IPC) (7,13).
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METHODS
Subjects. Subjects were examined at the IPC Center, a
medical center that is subsidized by the French national
health care system (Se´curite´ Sociale [CNAM]) and provides
free medical examinations for all working and retired
persons and their families. It is one of the largest medical
centers of this kind in France, having carried out approxi-
mately 20,000 to 25,000 examinations per year since 1970
for people living in the Paris area. Between January 1972
and December 1988, 139,315 individuals 40 to 70 years of
age (84,228 men and 55,087 women) had a free health
check-up at the IPC Center. Subjects who indicated that
they had previously been hospitalized for a heart attack,
cerebrovascular disease or other cardiac disease, as well as
those who presented clinical or electric signs of myocardial
infarction, heart failure stage III or IV or other major
cardiovascular diseases were excluded from the study (1,584
men and 1,606 women). Subjects with antihypertensive
treatment were also excluded from this analysis (4,564 men
and 4,160 women). An additional 1,848 subjects (1,057
men and 841 women) were not included for a variety of
reasons, such as missing clinical or mortality data or their
refusal to participate. All other subjects aged 40 to 70 years
were included in the present analysis.
In this study the data describe a population composed of
125,503 individuals (77,023 men and 48,480 women). The
IPC Center received authorization from the “Comite´ Na-
tional d’Informatique et des Liberte´s” to conduct these
analyses. All subjects gave their informed consent at the
time of the examination. Based on the national statistics of
mortality, our cohort presented a 20% lower mortality rate
than the general French population. This finding can be
explained by the assumption that people who came for the
health check-up were apparently healthy and motivated to
be followed up. Interestingly, compared with the national
data, the distribution of the different causes of mortality in
our cohort was identical to that of the general population.
Investigations. Supine BP was measured in the right arm
using a manual mercury sphygmomanometer, after a 10-
min rest period. The first and the fifth Korotkoff phases
were used to define systolic and diastolic pressures. Biolog-
ical parameters were measured under fasting conditions, and
electrocardiogram measurements were also recorded.
End points. For all screened subjects, vital status was
obtained for an 8- to 12-year period (mean 11.6 1 0.2),
which extended from the time of inclusion through Decem-
ber 1996. These data were obtained from the mortality
records of the “Institut National de Statistiques et d’Etudes
Economiques” (INSEE) after a previously described proce-
dure (7). Causes of mortality, taken from the death certif-
icates, were provided by INSERM’s Department of
Mortality Studies (Unit SC 8). Causes of death were
codified according to the International Classification of
Disease (8th revision until 1978 and 9th revision thereafter).
Cardiovascular-related deaths were coded 390 to 459 and
798 (sudden death). Permission to obtain mortality data was
given by the “Comite´ National de l’Informatique et des
Liberte´s.”
Data analysis. Men and women were studied separately.
They were divided into three groups of SBP. Inside each
SBP group, men were divided into four DBP groups,
whereas women were divided into three DBP groups.
Different classifications were necessary for men and women
due to the lower number of subjects and lower mortality
rates in women.
Differences in cardiovascular mortality among SBP
groups were calculated after adjustment for age by using a
Cox proportional hazards regression analysis. Cardiovascu-
lar deaths among the DBP groups, within each SBP group,
were compared with the use of a chi-square test. Differences
in survival probability for cardiovascular mortality, from one
DBP group to the other, were tested by using a Cox
proportional hazards regression analysis with adjustments
for age and SBP levels. Complementary adjustments for
other major cardiovascular risk factors (total cholesterol,
diabetes, and tobacco consumption) did not significantly
modify the results.
For cardiovascular mortality, the role of DBP within each
SBP group was also assessed when DBP was considered as
a continuous quantitative parameter. Risk ratios (RR) and
95% confidence intervals related to the increase of one
standard deviation of DBP were calculated using a Cox
proportional hazards regression analysis, after adjustment
for age and SBP or age, SBP and other risk factors (total
cholesterol, diabetes, tobacco consumption).
The level of statistical significance was 5%. All statistical
analyses were carried out using the SAS statistical software
package.
RESULTS
The general characteristics of the studied population are
shown in Table 1. During the follow-up period, a total of
4,055 men and 1,112 women died. Among them, 849 men
and 154 women died from cardiovascular-related diseases.
Characteristics of SBP/DBP groups. The different sub-
groups according to SBP and DBP in men and women,
Abbreviations and Acronyms
BP 5 blood pressure
CNAM 5 Se´curite´ Sociale (French national health
care system)
DBP 5 diastolic blood pressure
INSEE 5 Institut National de Statistiques et
d’Etudes Economiques
INSERM 5 National Institute of Medical Research
IPC Center 5 Centre d’Investigations Pre´ventives et
Cliniques
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RR 5 risk ratio
SBP 5 systolic blood pressure
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respectively, are shown in Tables 2 and 3. Within each SBP
group, the increase in mean arterial pressure in the higher
DBP groups was not only due to higher diastolic levels but
also to higher SBP levels. As the increase in SBP was less
pronounced than DBP, PP levels were lower in the higher
DBP groups. Total cholesterol, glycemia, triglycerides and
heart rate did not differ greatly among the DBP groups
(data not shown). In both genders, mortality clearly in-
creased in the higher SBP groups. Compared with the men
with normal SBP (,140 mm Hg), age-adjusted RR (95%
confidence intervals) for cardiovascular mortality was 1.57
(1.30 to 1.90) in men with borderline systolic hypertension
(SBP $140 to 149 mm Hg) and 2.99 (2.54 to 3.52) in men
with SBP $150 mm Hg. In women, similar results were
observed, and the respective relative risks were 2.75 (1.82 to
4.14) and 2.94 (1.96 to 4.42).
Mortality rates according to DBP for different levels of
SBP. Normal SBP group (,140 mm Hg). In men, unadjusted
cardiovascular mortality rates (Table 2, upper panel) were more
elevated in the higher DBP groups (trend test: p , 0.05).
However, after adjustment for age and SBP, cardiovascular
mortality was the same in the different DBP subgroups. A
similar result was observed when DBP was considered as a
continuous quantitative variable: age- and SBP-adjusted RR
for one standard deviation of DBP was 1.16 (0.92 to 1.45). In
women with normal SBP, cardiovascular mortality rates were
very low in all DBP subgroups without any significant differ-
ences among them (Table 3, upper panel).
Borderline systolic hypertension group (140 to 149 mm Hg).
As shown in Table 2 (middle panel), in men with borderline
systolic hypertension, the highest cardiovascular mortality rates
Table 1. Clinical Characteristics of the Studied Population
Men Women
Number 77,023 48,480
Age (yrs) 49.6 6 6.9 49.7 6 6.9
SBP (mm Hg) 137 6 16 131 6 16
DBP (mm Hg) 85 6 11 81 6 10
PP (mm Hg) 52 6 10 51 6 10
Total cholesterol (g/l) 2.29 6 0.40 2.22 6 0.41
Triglycerides (g/l) 1.28 6 0.88 0.82 6 0.53
Glycemia (g/l) 1.05 6 0.14 0.99 6 0.11
Current smokers (%) 23.9 12.1
Total deaths per thousand 52.6 (4,055)* 22.9 (1,112)
Cardiovascular deaths per thousand 11.0 (849) 3.2 (154)
*The absolute number of deaths is indicated in parentheses.
DBP 5 diastolic blood pressure; PP 5 pulse pressure; SBP 5 systolic blood
pressure.
Table 2. Mean Values for Age and Blood Pressure and Cardiovascular Deaths in Men
According to the SBP and DBP Groups
DBP Class (mm Hg)
SBP < 140
<70 70–79 80–89 >90 All
Number 1,433 9,970 25,669 4,602 41,674
Age (yrs) 47.4 6 6.3 47.9 6 6.3 48.6 6 6.4 48.9 6 6.2 48.4 6 6.4
SBP (mm Hg) 114 6 8 122 6 7 128 6 6 131 6 4 126 6 7
DBP (mm Hg) 62 6 4 71 6 2 81 6 2 91 6 2 79 6 7
PP (mm Hg) 52 6 8 50 6 7 47 6 5 40 6 4 47 6 7
MBP (mm Hg) 79 6 4 88 6 3 96 6 2 104 6 2 95 6 6
CVD deaths/thousand 1.4 (2)* 5.1 (51) 5.7 (147) 8.7 (40) 5.8 (240)
DBP Class (mm Hg)
SBP 5 140–149
<80 80–89 90–99 >100 All
Number 359 7,070 10,304 952 18,685
Age (yrs) 50.2 6 8.1 50.2 6 7.2 50.0 6 6.7 49.2 6 6.5 50.0 6 6.9
SBP (mm Hg) 141 6 2 142 6 2 143 6 2 144 6 3 142 6 2
DBP (mm Hg) 70 6 6 82 6 2 93 6 2 103 6 3 87 6 6
PP (mm Hg) 70 6 6 59 6 3 50 6 2 40 6 4 54 6 6
MBP (mm Hg) 94 6 4 101 6 2 107 6 1 116 6 2 105 6 4
CVD deaths/thousand 16.7 (6) 10.6 (75) 9.8 (101) 17.9 (17) 10.7 (199)
DBP Class (mm Hg)
SBP > 150
<90 90–99 100–109 >110 All
Number 1,316 6,350 6,090 2,908 16,664
Age (yrs) 53.0 6 8.3 52.2 6 7.3 51.7 6 7.1 52.3 6 7.3 52.0 6 7.4
SBP (mm Hg) 154 6 8 154 6 7 159 6 10 176 6 17 160 6 13
DBP (mm Hg) 81 6 5 92 6 2 102 6 2 115 6 8 98 6 10
PP (mm Hg) 73 6 9 63 6 7 59 6 10 61 6 14 62 6 11
MBP (mm Hg) 105 6 4 112 6 3 120 6 3 135 6 9 119 6 10
CVD deaths/thousand 28.1 (37) 19.8 (126) 21.4 (130) 40.2 (117) 24.6 (410)
*The absolute number of deaths is indicated in parentheses.
CVD 5 cardiovascular disease; DBP 5 diastolic blood pressure; MBP 5 mean blood pressure; PP 5 pulse pressure; SBP 5
systolic blood pressure.
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were observed in those with the lowest DBP (,80 mm Hg)
and the highest DBP levels ($100 mm Hg), whereas the
lowest cardiovascular mortality rates were recorded in subjects
with DBP .290 to 99 mm Hg (p , 0.05 vs. DBP , 80 or vs.
DBP ,2 100 mm Hg). However, after adjustment for age and
SBP, the influence of DBP on cardiovascular mortality was not
significant in this group; the RR for one standard deviation of
DBP was 1.05 (0.75 to 1.43).
Women with DBP $90 mm Hg had cardiovascular
mortality rates twice as high as those with low DBP (Table
3, middle panel) (p , 0.01). The difference among groups
was significant even after adjustment for age and SBP (p ,
0.01). When DBP was considered as a continuous variable,
age- and SBP-adjusted RR for one standard deviation of
DBP was 1.54 (0.97 to 4.46).
High SBP group (.2150 mm Hg). In men, the highest
unadjusted cardiovascular mortality rates were observed in
those with the lowest DBP levels and in those with the
highest DBP levels (Table 2, lower panel). The lowest
cardiovascular mortality rates were recorded in subjects with
DBP between 90 and 99 mm Hg. Compared with this
group, age- and SBP-adjusted cardiovascular mortality was
higher by 73% (p , 0.02) in the isolated systolic hyperten-
sion group, by 8% (NS) in the DBP 5 100 to 109 mm Hg
group and by 62% (p , 0.001) in the DBP .2 110 mm Hg
group (Fig. 1, left panel). When DBP was considered as a
continuous variable, age- and SBP-adjusted RR of cardio-
vascular mortality for one standard deviation of DBP was
0.99 (0.89 to 1.10). On the contrary, in women, the highest
DBP levels were associated with the highest cardiovascular
mortality rates (Table 3). This difference among groups was
significant even after adjustment for age and SBP (trend
test: p , 0.01) (Fig. 1, right panel). When DBP was
considered as a continuous variable, age- and SBP-adjusted
RR of cardiovascular mortality for one standard deviation of
DBP was 1.39 (1.03 to 1.87).
In men, PP was a significant determinant of cardiovas-
cular mortality. Relative risk for one standard deviation of
PP was 1.24 (1.16 to 1.33). In women, however, PP was not
significantly associated with cardiovascular mortality (RR: 0.93
[0.74 to 1.17]).
DISCUSSION
In a large middle-aged French population, we observed that
the role of DBP in cardiovascular mortality varies according to
gender and SBP level.
In both men and women with normal SBP (,140 mm Hg),
Table 3. Mean Values for Age and Blood Pressure and Cardiovascular Deaths in Women
According to the SBP and DBP Groups
DBP Class (mm Hg)
SBP < 140
<80 80–89 >90 All
Number 14,013 17,298 2,082 33,933
Age (yrs) 47.6 6 6.3 49.0 6 6.4 49.7 6 6.5 48.5 6 6.4
SBP (mm Hg) 118 6 8 127 6 6 130 6 4 123 6 8
DBP (mm Hg) 69 6 5 81 6 2 92 6 2 76 6 7
PP (mm Hg) 49 6 7 46 6 6 39 6 5 47 6 7
MBP (mm Hg) 85 6 5 96 6 2 104 6 2 92 6 7
CVD deaths/thousand 1.0 (14)* 1.7 (29) 1.4 (3) 1.4 (46)
DBP Class (mm Hg)
SBP 5 140–149
<90 90–99 >100 All
Number 3,848 4,224 232 8,304
Age (yrs) 51.9 6 7.1 51.3 6 6.8 50.0 6 6.9 51.5 6 7.0
SP (mm Hg) 141 6 2 142 6 2 143 6 3 141 6 2
DBP (mm Hg) 80 6 4 91 6 1 102 6 3 86 6 6
PP (mm Hg) 60 6 4 51 6 2 41 6 4 55 6 6
MBP (mm Hg) 100 6 2 107 6 1 115 6 2 104 6 4
CVD deaths/thousand 4.2 (16) 9.2 (30) 8.6 (2) 5.8 (48)
DBP Class (mm Hg)
SBP> 150
<90 90–99 >100 All
Number 793 3,035 2,955 6,783
Age (yrs) 53.8 6 8.0 54.0 6 7.3 53.4 6 7.4 53.9 6 7.5
SBP (mm Hg) 154 6 8 155 6 8 165 6 15 159 6 12
DBP (mm Hg) 81 6 4 92 6 2 104 6 7 95 6 9
PP (mm Hg) 73 6 9 64 6 8 61 6 12 64 6 11
MBP (mm Hg) 105 6 4 112 6 3 125 6 8 117 6 9
CVD deaths/thousand 3.8 (3) 7.3 (22) 11.8 (35) 8.9 (60)
*The absolute number of deaths is indicated in parentheses.
CVD 5 cardiovascular disease; DBP 5 diastolic blood pressure; MBP 5 mean blood pressure; PP 5 pulse pressure; SBP
5 systolic blood pressure.
166 Benetos et al. JACC Vol. 37, No. 1, 2001
DBP and Cardiovascular Mortality January 2001:163–8
DBP was not a significant determinant of cardiovascular
mortality, after adjustment for age and SBP.
In men with systolic hypertension, a U-shaped curve
relationship between cardiovascular mortality and DBP was
observed. The highest cardiovascular death rates were re-
corded in men with DBP values less than 90 mm Hg
(isolated systolic hypertension) and in those with DBP
values greater than 110 mm Hg.
In women with systolic hypertension, however, DBP was
positively correlated with cardiovascular mortality; women
with isolated systolic hypertension were at a much lower risk
than those with systolic-diastolic hypertension.
SBP/DBP and risk determination. In various epidemio-
logical studies both SBP and DBP have been shown to be
associated with cardiovascular risk (1–4). A predominant
role of SBP has been pointed out, especially in older subjects
(4,14). A number of studies have also shown that, even in
middle-aged populations, SBP is a stronger predictor of
coronary heart disease than DBP (15,16). Based on the
analyses of the Multiple Risk Factor Intervention Trial
(MRFIT) database, Neaton et al. (15) showed that, in white
men aged 35 to 57, differences in coronary mortality among
DBP categories for each SBP category were small. On the
contrary, a strong risk gradient was evident for SBP for each
DBP category. They also showed that the highest coronary
age-adjusted mortality rates were observed in the group with
the higher SBP (.160 mm Hg) and the lower DBP
(,70 mm Hg). The authors suggested that this group
might include men with pre-existing heart disease. A recent
analysis of the Framingham population by Franklin et al.
(16) showed that, in men and women (studied together)
aged 50 to 79 without pre-existing heart disease, coronary
risk strongly increased with higher SBP. This risk also
increased with lower DBP for any given level of SBP. In our
analysis, all subjects with pre-existing cardiovascular disease
were excluded. In this population (which was younger than
the one studied by Franklin et al. [16]), we also found a
higher risk of cardiovascular mortality with lower DBP, but
only in men and especially in those with high SBP.
Gender differences in the role of DBP. No such U-shaped
curve was observed in the women of our population. To the
best of our knowledge, most of the studies conducted so far
have evaluated the role of SBP and DBP only in male or in
mixed populations, without separate analyses for women. The
authors of a recent analysis of the respective roles of SBP and
DBP in the Framingham population reported that gender was
not a significant determinant in the relationship between DBP
and coronary mortality (16). However, subjects up to 79 years
of age were included in that study. We previously reported that
the role of PP was not the same in men as it was in women
(17). Actually, no association between cardiovascular mortality
and PP was observed in either normotensive or hypertensive
women. In that study, we had suggested that low mortality
rates could explain this observation in normotensive, but not in
hypertensive, women for whom cardiovascular mortality rates
were relatively high. Low mortality rates in women could also
be one of the explanations for the absence of any association
between SBP, DBP or PP and cardiovascular mortality in
untreated women of the Medical Research Council (MRC)
trial (18). Despite low cardiovascular rates in women observed
in this study, our results clearly show that, in women, cardio-
vascular mortality is positively correlated with DBP levels
without any trend toward a U-shaped curve.
Arterial determinants of SBP, DBP and PP. Although
SBP increases with an elevation in total peripheral resistance
or an increase in large artery stiffness, DBP levels are
Figure 1. Age- and SBP-adjusted cardiovascular mortality rates calculated with a Cox proportional hazards regression for men (left panel) and women
(right panel) with high SBP ($150 mm Hg) according to DBP levels. For the same SBP level, a U-shaped relationship between DBP and cardiovascular
mortality was observed in men. In women, however, this relationship was linear. DBP 5 diastolic blood pressure; SBP 5 systolic blood pressure. *p , 0.02;
**p , 0.001 vs. DBP 90 to 99 mm Hg; †p , 0.01 (chi-square trend test).
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influenced by arterial or arteriolar alterations in opposite
ways; an increase in peripheral vascular resistance leads to an
elevation in DBP, whereas stiffening of large arteries can
contribute to a decrease in DBP (19,20). Therefore, normal
levels of DBP may be due to the combination of these two
vascular alterations, which are both independent risk factors
of cardiovascular disease, especially coronary artery disease.
This leads to the conclusion that levels of DBP may not
necessarily reflect cardiovascular risk, especially in subjects
whose SBP is disproportionally elevated, i.e., those in whom
arterial stiffness is more pronounced. Our results show that
the U-shaped relationship between DBP and cardiovascular
mortality was observed in men with high SBP. This
suggests that, among men with systolic hypertension, two
high risk subgroups can be identified, one with very low
DBP (,90 mm Hg) and, therefore, high PP, the main
indicator of pronounced large artery stiffness, and one with
very high DBP ($110 mm Hg), where the main alteration
is an elevation of peripheral resistance.
Our results suggest that arterial stiffness in women
develops later in life, and, therefore, low DBP is mainly an
indicator of low peripheral resistance and not, as has been
observed in men, an indicator of pronounced large artery
stiffness. It would be interesting to evaluate whether or not
these findings are similar in older women.
Study limitations. Our study presents some limitations.
One limitation is that BP values are based on a single visit,
therefore, not enabling us to clearly identify people with
permanently elevated BP. However, it has previously been
reported that multiple BP measurements added little to
determining the risk already predicted by a single measure-
ment (21,22). Another limitation is the lack of information
about possible antihypertensive treatment after the visit.
One could assume that patients with high levels of both
SBP and DBP were more likely to receive treatment after
the visit than those with high SBP and low DBP. This was
especially true in the 1980s when, in the majority of cases,
isolated systolic hypertension was not treated. However,
possible subsequent treatment cannot entirely explain the
relationship between DBP and cardiovascular mortality.
However, if subsequent treatment was the reason for lower
mortality rates in subjects with systolic-diastolic hyperten-
sion, similar results should also be observed in women. It is
interesting to note that Franklin et al. (16) reported that
taking into account postbaseline antihypertensive treatment
had little or no effect on the cardiovascular risk as evaluated
during the pretreatment visit.
In conclusion, in middle-aged subjects, classification of
cardiovascular risk according to DBP levels should take into
account gender, especially when SBP levels are elevated.
Men with systolic hypertension are at higher risk when their
DBP is “normal” than when they present a mild to moderate
increase in DBP. In women of the same age, however,
systolic-diastolic hypertension represents a higher risk than
isolated systolic hypertension.
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